Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis

Digestive Diseases and Sciences

Volumn 50, Issue 5, 2005, Pages 964-969

  Uraz, Suleyman ^a   Aygun, Cem ^b   Sonsuz, Abdullah ^b   Ozbay, Gulsen ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hepatic iron overload; Nonalcoholic steatohepatitis; Serum iron levels

Indexed keywords

ALBUMIN; AMINOTRANSFERASE; EOSIN; FERRITIN; GLOBULIN; HEMATOXYLIN; IRON;

ADULT; ALBUMIN BLOOD LEVEL; ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; FEMALE; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL; VIRUS HEPATITIS;

ADULT; FATTY LIVER; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; IRON; IRON OVERLOAD; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 18844457410     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2672-z     Document Type: Article

References (32)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-438, 1980
2. Brunt EM: Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21:3-16, 2001
3. Bugianesi E, Leone N, Vanni E, et al.: Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123:134-140, 2002
4. Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ: Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2:17-26, 2001
5. Day CP, James OF: Steatohepatitis: A tale of two "hits"? Gastroenterology 114:842-845, 1998
6. Marchesini G, Brizi M, Morselli-Labate AM, et al.: Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107:450-455, 1999
7. Marchesini G, Bugianesi E, Forlani G, et al.: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917-923, 2003
8. Chitturi S, Abeygunasekera S, Farrell GC, et al.: NASH and insulin resistance: insulin secretion and specific association with the insulin resistance syndrome. Hepatology 35:373-379, 2002
9. Leclercq IA, Farrel GC, Field J, et al.: CYP2E1 and CYP4A as microsomal catalyss of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105:1067-1075, 2000
10. Vendemiale G, Grattagliano I, Caraceni P, et al.: Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 33:808-815, 2001
11. Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, Banner BF: Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 31:421- 429, 1999
12. George DK, Goldwurm S, MacDonald GA, et al.: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311-318, 1998
13. Chitturi S, Weltman M, Farrell GC, et al.: HFE mutations, hepatic iron, and fibrosis: ethnic specific association of NASH with C282Y but not with fibrotic severity. Hepatology 36:142-149, 2002
14. Younossi ZM, Gramlich T, Bacon BR, Matteoni CA, Boparai N, O'Neill R, McCullough AJ: Hepatic iron and nonalcoholic fatty liver disease. Hepatology 30:847-850, 1999
15. Hultcrantz R, Bissell DM, Roll FJ: Iron mediates production of a neutrophil chemoattractant by rat hepatocytes metabolizing ethanol. J Clin Invest 87:45-49, 1991
16. Bacon B, Britton R: The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 11:127-137, 1990
17. Bacon B, O'Neill R, Britton R: Hepatic mitochondrial energy production in rats with chronic iron overload. Gastroenterology 105:1134-1140, 1993
18. George DK, Goldwurm S, Macdonalds GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW: Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114:311-318, 1998
19. Fabris C, Toniutto P, Scott CA, Falleti E, Avellini C, Forno MD, Mattiuzzo M, Branca B, Pirisi M: Serum iron indices as a measure of iron deposits in chronic hepatitis C. Clin Chem 304:49-55, 2001
20. Pietrangelo A, Gualsi R, Casalgrandi G, Geerts A, De Bleser P, Mantosi G, Ventura E: Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology 19:714-921, 1994
21. Friedman S: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328:1828-1835, 1993
22. Chapoutot C, Esslimani M, Joomaye Z, Ramos J, Perney P, Laurent C, Peray PF, Larrey D, Domergue J, Blanc F: Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis. Gut 46:711-714, 2000
23. Hezode C, Cazeneuve C, Coue O, Thoraval FR, Lonjon I, Bastie A, Duvoux C, Pawlotsky JM, Zafrani ES, Amselem S, Dhumeaux D: Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. J Hepatol 31:979-984, 1999
24. Beinker NK, Voight MD, Arendse M, Smith J, Stander IA, Kirsh RE: Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatit B and C. J Hepatol 25:633-638, 1996
25. Farinati F, Cardin R, Maria ND, Libera GD, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22:449-456, 1995
26. Negro F, Sammi K, Brandt LR, Quadri R, Male PJ, Zarski JP, Baud M, Giostra E, Beris P, Hadengue A: Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis. J Med Virol 60:21-27, 2000
27. Bacon BR, Farahvash MJ, Janney GC, Tetri BA: Nonalcoholic steatohepatitis: an expanded clinical entity.Gastroenterology 107:1103-1109, 1994
28. Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM, Bowman BA, Grummer-Strawn LM, Sampson EJ, Khoury MJ, Gallagher ML: Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 285:2216-2222, 2001
29. Hanson EH, Imperatore G, Burke W: HFE gene and hereditary hemochromatosis: a HuGE review. Human genome epidemiology. Am J Epidemiol 154:193-206, 2001
30. Cassanelli S, Pignatti E, Montosi G, Garuti C, Mariano M, Campioli D, Carbonieri A, Baldini E, Pietrangelo A: Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. J Hepatol 34:523-528, 2001
31. Barut G, Balci H, Bozdayi M, Hatemi I, Ozcelik D, Senturk H: Screening for iron overload in the Turkish population. Dig Dis Sci 21(3):279-285, 2003
32. Bozkaya H, Bektas M, Metin O, et al.: Screening for hemochromatosis in Turkey. Dig Dis Sci 49(3):444-449, 2004